Methylnaltrexone
Indication
Opioid induced bowel dysfunction in palliative care (NICE TA 277 terminated)
NICE is unable to recommend the use in the NHS because no evidence submission was received from the manufacturer of the technology
NICE TA277 - Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal)
Black
Brand:
Nice TA:
277 (terminated)
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Gastro-intestinal system
Background
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: